News
A researcher at Duke University, speaks out after her NIH grant for sickle cell research was terminated. The $750,000 funding ...
13h
The Punch on MSNSickle cell disease and healthcare inequitiesSickle cell disease is one of the most common genetic blood disorders in the world. It affects millions globally, with the highest burden seen in people of African, Caribbean, Middle Eastern, and ...
Sickle cell disease affects about 100,000 people in the U.S., and 90% of patients are Black, according to NIH.
Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new ...
Beam Therapeutics Inc. (NASDAQ:BEAM) ranks among the best CRISPR stocks to buy. On June 13, Beam Therapeutics Inc.
To mark four years of sharing his experiences through writing, columnist Dunstan Nicol-Wilson reflects on the journey with gratitude.
As a result of being a caregiver for her cousin, columnist Sylvia Amuta says she's now more caring, compassionate, and kind to others.
Stem-cell research is the area of research that studies the properties of stem cells and their potential use in medicine. As stem cells are the source of all tissues, understanding their ...
Two rival CAR-Ts are currently approved by the FDA for relapsed or refractory B-cell precursor ALL, namely Novartis' Kymriah (tisagenlecleucel) and Gilead/Kite's Tecartus (brexacabtagene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results